GlassScriptPhysician profile
Gary A Rath
NPI 1144284456
$2,445.87
in general payments reported to CMS, 2019-2025
22 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $160 · 2021: $153 · 2022: $295 · 2023: $114 · 2024: $1,384 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $906 · Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $905.94 |
| Food and Beverage | $770.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,060.49 | 2024 | Glidesheath Slender, Metacross Otw |
| Shockwave Medical, INC | $477.61 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $182.35 | 2019-2021 | |
| Abiomed | $165.23 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $73.47 | 2019-2022 | |
| Amgen INC. | $66.96 | 2019-2020 | |
| Pfizer INC. | $54.90 | 2025 | |
| Medtronic, INC. | $54.71 | 2021-2023 | Linq II |
| Abbott Laboratories | $46.63 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.72 | 2022-2023 | Lifevest |
| Heartflow, INC. | $35.19 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $23.43 | 2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $22.17 | 2019 | |
| Astellas Pharma US INC | $19.76 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.64 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $18.35 | 2022 | |
| Ge Healthcare | $16.88 | 2023 | |
| Medtronic Vascular, INC. | $16.46 | 2020 | |
| Daiichi Sankyo INC. | $13.44 | 2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.03 | 2020 | |
| Asahi Intecc USA, INC. | $12.92 | 2021 | |
| W. L. Gore & Associates, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Rath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.